SIMICA is a @EU_Commission Twinning @immolecular to promote scientific excellence & research on therapeutic site-selective protein-modification chemistries
Our paper on the preclinical efficacy of a highly stable de novo protein decoy against SARS-CoV-2 infection is out! 🥳 @gbernardes_chem @ClaireTang20@AnaRaquelCoelh5@neoleukin @IMMolecular https://t.co/PaoXvrxaNm
"All those experiences made me who I am."
From being a taxi driver to becoming a Nobel Prize laureate - 2018 chemistry laureate @francesarnold describes how a diversity of experiences shapes you as a human being.
Generative AI for protein design is now one click away. We've launched a new platform that puts powerful tools behind a simple web interface, making #proteindesign accessible to anyone.
Try it here ➡️ https://t.co/onFokqOOYZ
Learn more on YouTube ➡️ https://t.co/4uzNC1KLFs
Thiomethyltetrazines are reversible covalent cysteine warheads whose reversibility can be "switched off” via live cell bioorthogonal chem, providing stability to lysis/proteomics. Led by @TallonAmanda w/ @Pfizer Mary Xu, Graham West & @ChrisamEnde1 10.26434/chemrxiv-2023-w0p5m
Excited to invite Dr Emma Yates (co-founder & CSO of Proteotype) presenting on Monday Lecture @IMMolecular today! Amazing and interesting talk about developing a novel technique for early stage cancer diagnosis. @gbernardes_chem
Tomorrow, Raphaël Rodriguez will present his most recent work about the prevalent role of d-block metals in the regulation of cell plasticity, entitle "Discovery of a metal-driven signaling pathway that regulates cell plasticity". Do not miss it. @institut_curie @immolecular
I am thrilled to announce that Prof. Gonçalo Bernardes @gbernardes_chem from @Cambridge_Uni has joined @BioconjChem as Associate Editor! Gonçalo brings expertise in protein modification, targeted therapeutics, and bioorthogonal chemistry. https://t.co/7P9bplIHrc @ACSPublications
Fluorescent amino acids are getting SMALLER, acid-stable & compatible for peptide-PAINT. Terrific work led by Fabio & Zuzanna with many collaborators. We share Fmoc/Boc analogues for your peptides, get in touch! @MathewHHorrocks@ERC_Research Free link▶️ https://t.co/SmZlufUTsx
Delighted to share the preclinical studies of JS25, a selective BTK inhibitor, with potent efficacy in blood cancers relative to other BTK inhibitors used in the clinic. A special thank you to all the collaborators and to my supervisor @gbernardes_chem.
https://t.co/apptYZFqOE
Very happy to talk about ADC & bioconjugates from a development and manufacturing perspective at @SIMICA_iMM. This is a side of the history we don’t hear much in R&D and I am so glad with the positive responses! Thanks @gbernardes_chem for the invitation 🤩! @LonzaGroup